FINWIRES · TerminalLIVE
FINWIRES

Germany's Manufacturing Production Contracts in February on Lower Pharmaceuticals, Electronics Output

-- Production in Germany's manufacturing sector unexpectedly declined month over month in February, even before the war in the Middle East began, as output from the pharmaceuticals and electronics industries weakened, provisional data from the Federal Statistical Office showed Thursday.

Real, price-adjusted manufacturing output dropped 0.3% in February, after seasonal and calendar changes, compared with the upwardly revised stagnation in January. The consensus estimate for February was a 0.9% rise.

On a monthly basis, production of pharmaceuticals and computer, electronic, and optical products contracted 4.4% and 3.9%, respectively. Amid the cold winter weather, construction output slipped 1.2%, while automotive production improved 1.7%. Destatis data paints a picture of a "very reluctant, hesitant consumer," while the manufacturing sector struggles to gain positive momentum, said Carsten Brzeski, the global head of macro at ING.

Annually, German manufacturing output after calendar adjustment was stable, against the revised 0.9% decrease in January. Excluding energy and construction, industrial production in February slipped 0.1% on the month and 0.6% on the year.

In energy-intensive industries, which account for 17% of industrial gross value, production expanded 1.9% month over month and 0.1% on a yearly basis. Consumer goods production fell 1.5% sequentially, while the output of intermediate goods and capital goods rose by 0.4% and 0.1%, respectively. Germany, one of Europe's largest net importers of energy, clocked a 0.3% monthly gain in energy production in February.

"All in all, February's macro data shows that even without the war in the Middle East, the German economy was unfortunately on track for yet another quarter of contraction. To make things worse, the war in the Middle East, no matter how sustainable yesterday's announced ceasefire will prove to be, will leave clear marks on the German economy over the next few months. As much as we were hoping to finally comment on some good economic news from Germany, it is a bit like waiting for a German train these days: definitely delayed and uncertain whether it will ever arrive," Brzeski concluded.

相关文章

Asia

印度Shakti Pumps公司投资1亿印度卢比用于电动汽车移动出行部门

据周二提交给印度证券交易所的文件显示,Shakti Pumps (India)(NSE:SHAKTIPUMP,BOM:531431)宣布,已通过认购1000万股股权,向其全资子公司Shakti EV Mobility投资1亿印度卢比。 该公司股价在周三的交易中上涨了1%。 文件称,此次投资使Shakti Pumps对这家电动汽车出行子公司的总投资额增至6.5亿印度卢比。 文件还补充道,此次投资旨在支持该子公司的业务扩张。

$BOM:531431$NSE:SHAKTIPUMP
Asia

Jarden表示,Challenger 2026财年第三季度业绩更新在关键生命指标方面未达预期。

根据Jarden周二发布的报告,Challenger(ASX:CGF)2026财年第三季度业绩更新未能达到市场预期,关键寿险指标均低于预期,其中基金管理业务的资金流出远超预期,主要原因是澳大利亚和全球股票的机构股票投资组合流失。 该公司于5月25日赎回了所有CGFPC债券,此举简化了资本结构,降低了AT1债券的票息负担,并提升了每股收益。 Jarden认为Challenger未来风险/回报平衡,其利好因素包括澳大利亚审慎监管局改革带来的资本管理灵活性,以及养老基金退休合作项目的拓展。 Jarden下调了Challenger 2026财年的销售预期,以反映机构定期寿险销售疲软,但随着合作项目的上线,零售年金销售额的增长部分抵消了这一影响。 该投资公司维持对Challenger的“中性”评级,并将目标股价从每股8.60澳元上调至每股8.70澳元。

$ASX:CGF
Asia

Proya Cosmetics 2025年利润下降4%,营收下滑2%

普罗雅化妆品(上海证券交易所代码:603605)公布2025财年净利润为15亿元人民币,较上年同期的15.5亿元人民币下降3.5%。 根据周三提交给上海证券交易所的文件,每股收益从3.92元人民币下滑至3.80元人民币。 营业收入同比下降1.7%,从108亿元人民币降至106亿元人民币。 该化妆品公司股价在近期交易中上涨超过1%。

$SHA:603605